Zacks Investment Management Haemonetics Corp Transaction History
Zacks Investment Management
- $9.31 Billion
- Q1 2024
A detailed history of Zacks Investment Management transactions in Haemonetics Corp stock. As of the latest transaction made, Zacks Investment Management holds 13,708 shares of HAE stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,708
Previous 10,824
26.64%
Holding current value
$1.17 Million
Previous $925,000
26.38%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding HAE
# of Institutions
310Shares Held
50.1MCall Options Held
161KPut Options Held
56.3K-
Capital Research Global Investors Los Angeles, CA6.67MShares$571 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.98MShares$512 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$462 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.27MShares$365 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY3.79MShares$324 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.39B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...